{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:50:13Z","timestamp":1793717413164,"version":"4.6.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007924","name":"University of Louisville","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.canlet.2026.218416","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:45:20Z","timestamp":1773074720000},"page":"218416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Exosomal cannabidiol: A promising candidate for targeted oral delivery against breast cancer"],"prefix":"10.1016","volume":"646","author":[{"given":"Disha Nagesh","family":"Moholkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9202-4071","authenticated-orcid":false,"given":"Raghuram","family":"Kandimalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyaprakash","family":"Jeyabalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8559-8798","authenticated-orcid":false,"given":"Richa","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2922-9151","authenticated-orcid":false,"given":"Katarina","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3358-4378","authenticated-orcid":false,"given":"Carolyn M.","family":"Klinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7086-0802","authenticated-orcid":false,"given":"Ramesh C.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0081-7251","authenticated-orcid":false,"given":"Farrukh","family":"Aqil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218416_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7812\/TPP\/14-241","article-title":"PhillipTuso, breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations","volume":"19","author":"Ibodai","year":"2015","journal-title":"Perm. J."},{"key":"10.1016\/j.canlet.2026.218416_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174287","article-title":"Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment Strategies-An updated review","volume":"13","author":"\u0141ukasiewicz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218416_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.53331","article-title":"Breast cancer incidence among US women aged 20 to 49 years by race, stage, and hormone receptor status","volume":"7","author":"Xu","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.canlet.2026.218416_bib4","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218416_bib5","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3892\/ijo.2020.5135","article-title":"Triple-negative breast cancer therapy: current and future perspectives","volume":"57","author":"Won","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2026.218416_bib6","series-title":"Triple-Negative Breast Cancer","author":"Society","year":"2023"},{"key":"10.1016\/j.canlet.2026.218416_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/biom13081207","article-title":"Challenges and opportunities in developing targeted therapies for triple negative breast cancer","volume":"13","author":"Chapdelaine","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.canlet.2026.218416_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2018-000357","article-title":"How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies","volume":"3","author":"Park","year":"2018","journal-title":"ESMO Open"},{"key":"10.1016\/j.canlet.2026.218416_bib9","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s13346-018-0551-3","article-title":"Metastatic and triple-negative breast cancer: challenges and treatment options","volume":"8","author":"Al-Mahmood","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.canlet.2026.218416_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cpet.2018.02.006","article-title":"Overview of breast cancer therapy","volume":"13","author":"Moo","year":"2018","journal-title":"Pet. Clin."},{"key":"10.1016\/j.canlet.2026.218416_bib11","first-page":"721","article-title":"Breast cancer: an overview of current therapeutic strategies, challenge, and perspectives","volume":"15","author":"Wang","year":"2023","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.canlet.2026.218416_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000508759","article-title":"Optimal systemic treatment for early triple-negative breast cancer","volume":"15","author":"Furlanetto","year":"2020","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.canlet.2026.218416_bib13","series-title":"Marihuana: the First Twelve Thousand Years","author":"Abel","year":"2013"},{"key":"10.1016\/j.canlet.2026.218416_bib14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1186\/s12885-025-14175-z","article-title":"Cannabidiol as a novel therapeutic agent in breast cancer: evidence from literature","volume":"25","author":"Esmaeli","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2026.218416_bib15","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.canlet.2026.218416_bib16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40263-020-00741-5","article-title":"Critical aspects affecting cannabidiol oral bioavailability and metabolic elimination, and related clinical implications","volume":"34","author":"Perucca","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.canlet.2026.218416_bib17","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1016\/j.xphs.2021.03.028","article-title":"Comparative study of dissolution for cannabidiol in EU and US hemp oil products by HPLC","volume":"110","author":"Analakkattillam","year":"2021","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.canlet.2026.218416_bib18","article-title":"Oral delivery of cannabidiol: revealing the formulation and absorption challenges","volume":"92","author":"Sitovs","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.canlet.2026.218416_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125710","article-title":"Cannabidiol-loaded-injectable depot formulation for the treatment of triple-negative breast cancer: design, development, in-vitro and in-ovo evaluation of its anticancer activity","volume":"678","author":"Lozza","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.canlet.2026.218416_bib20","article-title":"Preparation and characterization of PBS (Polybutylene succinate) nanoparticles containing cannabidiol (CBD) for anticancer application","volume":"97","author":"Freire","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.canlet.2026.218416_bib21","doi-asserted-by":"crossref","first-page":"21568","DOI":"10.1021\/acsomega.5c00689","article-title":"Codelivery of paclitaxel and cannabidiol in lipid nanoparticles enhances cytotoxicity against melanoma cells","volume":"10","author":"de Carvalho","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.canlet.2026.218416_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218416_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13349","article-title":"Milk exosomes - a biogenic nanocarrier for small molecules and macromolecules to combat cancer","volume":"85","author":"Kandimalla","year":"2021","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.canlet.2026.218416_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2022.100917","article-title":"Folate receptor as a biomarker and therapeutic target in solid tumors","volume":"47","author":"Young","year":"2023","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.canlet.2026.218416_bib25","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.3390\/cancers13153700","article-title":"Targeted oral delivery of paclitaxel using colostrum-derived exosomes","volume":"13","author":"Kandimalla","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218416_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202400362","article-title":"Targeted oral delivery of exosomal formulation of cannabidiol against lung cancer","author":"Moholkar","year":"2025","journal-title":"Adv. Therapeut."},{"key":"10.1016\/j.canlet.2026.218416_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216141","article-title":"Milk\/Colostrum exosomes: a nanoplatform advancing delivery of cancer therapeutics","volume":"561","author":"Wallen","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218416_bib28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2021.02.011","article-title":"Exosome-mediated delivery of RNA and DNA for gene therapy","volume":"505","author":"Munagala","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218416_bib29","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1186\/1471-2407-14-762","article-title":"Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance","volume":"14","author":"Kenicer","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2026.218416_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246248","article-title":"Anthocyanidins inhibit growth and chemosensitize triple-negative breast cancer via the NF-kappaB signaling pathway","volume":"13","author":"Aqil","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218416_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232565","article-title":"An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays","volume":"15","author":"Suarez-Arnedo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218416_bib32","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/intimm\/13.12.1551","article-title":"Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies","volume":"13","author":"Ober","year":"2001","journal-title":"Int. Immunol."},{"key":"10.1016\/j.canlet.2026.218416_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.canlet.2026.218416_bib34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.canlet.2026.218416_bib35","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218416_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tem.2021.12.003","article-title":"Emerging roles for folate receptor FOLR1 in signaling and cancer","volume":"33","author":"Nawaz","year":"2022","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.canlet.2026.218416_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072429","article-title":"CBD reverts the mesenchymal invasive phenotype of breast cancer cells induced by the inflammatory cytokine IL-1\u03b2","volume":"21","author":"Garc\u00eda-Morales","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218416_bib38","doi-asserted-by":"crossref","first-page":"29668","DOI":"10.18632\/oncotarget.9408","article-title":"Novel role of cannabinoid receptor 2 in inhibiting EGF\/EGFR and IGF-I\/IGF-IR pathways in breast cancer","volume":"8","author":"Elbaz","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218416_bib39","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1535-7163.MCT-10-1100","article-title":"Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy","volume":"10","author":"Shrivastava","year":"2011","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218416_bib40","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","article-title":"A systematic review on the pharmacokinetics of cannabidiol in humans","volume":"9","author":"Millar","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218416_bib41","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3389\/fonc.2019.01370","article-title":"Role of matrix metalloproteinases in angiogenesis and cancer","volume":"9","author":"Quintero-Fabi\u00e1n","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218416_bib42","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.molonc.2014.12.010","article-title":"Modulation of the tumor microenvironment and inhibition of EGF\/EGFR pathway: novel anti-tumor mechanisms of cannabidiol in breast cancer","volume":"9","author":"Elbaz","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.canlet.2026.218416_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.593195","article-title":"Role of PRDM1 in tumor immunity and drug response: a pan-cancer analysis","volume":"11","author":"Shen","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218416_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1176647","article-title":"Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218416_bib45","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1158\/1078-0432.CCR-21-0361","article-title":"IL13R\u03b12 promotes proliferation and outgrowth of breast cancer brain metastases","volume":"27","author":"M\u00e1rquez-Ortiz","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218416_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/biology11060817","article-title":"Mechanisms of cannabidiol (CBD) in cancer treatment: a review","volume":"11","author":"Heider","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.canlet.2026.218416_bib47","first-page":"10","article-title":"Regulatory effects of cannabidiol on mitochondrial functions: a review","author":"Chan","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218416_bib48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2021036301","article-title":"Role of exosomes for delivery of chemotherapeutic drugs","volume":"38","author":"Gebeyehu","year":"2021","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.canlet.2026.218416_bib49","article-title":"Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019","volume":"2","author":"Jianhui","year":"2023","journal-title":"BMJ Oncol."},{"key":"10.1016\/j.canlet.2026.218416_bib50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/ph17020244","article-title":"Strategies to improve cannabidiol bioavailability and drug delivery","volume":"17","author":"O'Sullivan","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.canlet.2026.218416_bib51","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/ijms21030747","article-title":"The endocannabinoid system: a target for cancer treatment","volume":"21","author":"Laezza","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218416_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25204682","article-title":"Cannabinoid combination induces cytoplasmic vacuolation in MCF-7 breast cancer cells","volume":"25","author":"Schoeman","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.canlet.2026.218416_bib53","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1208\/s12248-017-0154-9","article-title":"Exosomes for the enhanced tissue bioavailability and efficacy of curcumin","volume":"19","author":"Aqil","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.canlet.2026.218416_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.808614","article-title":"Exosomes: biological pharmaceutical nanovectors for theranostics","volume":"9","author":"Thomas","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.canlet.2026.218416_bib55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2021.02.011","article-title":"Exosome-mediated delivery of RNA and DNA for gene therapy","volume":"505","author":"Munagala","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218416_bib56","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.7150\/thno.125096","article-title":"Tumor-targeted exosomal delivery of celastrol for enhanced therapeutic efficacy in NSCLC","volume":"16","author":"Moholkar","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218416_bib57","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.apsb.2021.01.014","article-title":"Intranasal temperature-sensitive hydrogels of cannabidiol inclusion complex for the treatment of post-traumatic stress disorder","volume":"11","author":"Pang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.canlet.2026.218416_bib58","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/aps.2016.149","article-title":"Brain cannabinoid receptor 2: expression, function and modulation","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.canlet.2026.218416_bib59","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10585-007-9123-5","article-title":"Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms","volume":"24","author":"Eccles","year":"2007","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2026.218416_bib60","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3892\/ol.2024.14567","article-title":"Role of AMIGO2 in cancer progression: novel insights","volume":"28","author":"Tian","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2026.218416_bib61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/PAI.0b013e3182329e8f","article-title":"Laminin 332 expression in breast carcinoma","volume":"20","author":"Kwon","year":"2012","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.canlet.2026.218416_bib62","doi-asserted-by":"crossref","first-page":"6787","DOI":"10.18632\/oncotarget.14290","article-title":"EglN2 contributes to triple negative breast tumorigenesis by functioning as a substrate for the FBW7 tumor suppressor","volume":"8","author":"Takada","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218416_bib63","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1182\/blood-2005-09-3778","article-title":"Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas","volume":"107","author":"Tam","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218416_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.849701","article-title":"ICAM-1 on breast cancer cells suppresses lung metastasis but is dispensable for tumor growth and killing by cytotoxic T cells","volume":"13","author":"Regev","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218416_bib65","article-title":"Loss of DLG5 promotes breast cancer malignancy by inhibiting the hippo signaling pathway","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218416_bib66","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2015.10.020","article-title":"Bovine milk-derived exosomes for drug delivery","volume":"371","author":"Munagala","year":"2016","journal-title":"Cancer Lett."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:39:17Z","timestamp":1776857957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526001795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":66,"alternative-id":["S0304383526001795"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218416","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomal cannabidiol: A promising candidate for targeted oral delivery against breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218416"}}